Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Activist Investors Seek Action At Allergan, But Are They Aligned?

Jun 07 2018

• By Mandy Jackson

sales manager giving advice to his couple clients

Related Content

Pfizer, Allergan In Third-Biggest Merger Ever

Nov 23 2015

Shire Rejects Multiple Equity-Loaded Takeda Offers, Allergan Declines To Bid

Apr 19 2018

Allergan Performs Better Than Expected, But Still Conducting Strategic Review

May 01 2018

Liver Damage Worries Lead To Further EU Restrictions On Richter’s Esmya

May 21 2018

No Fire Sale: Allergan May Sell Women’s Health, Infectious Disease Units

May 30 2018

Allergan's Back In The (M&A) Saddle Again Post Pfizer Breakup

Apr 07 2016

Allergan May Rue Mohawk Tribe Deal As Court Invalidates Restasis Patents

Oct 17 2017

Allergan Shifts Restasis Patents To Native American Tribe To Invoke Immunity From IPR

Sep 09 2017

Former Bausch + Lomb CEO Saunders to head Forest; Icahn approves

Sep 11 2013

Related Companies

Allergan plc

Takeda Pharmaceutical Co. Ltd.

Takeda Pharmaceutical Co. Ltd.

Forest Laboratories, Inc.

Pfizer Inc.

Additional Topics

Business Strategies Companies Leadership Commercial BioPharmaceutical

More from Strategy

More from Business

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window